Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study

被引：0
|
作者：
Birkeland, K. [1 ]
Bodegard, J. [2 ]
Eriksson, J. [3 ]
Norhammar, A. [4 ]
Thuresson, M. [5 ]
Pignot, M. [6 ]
Garal-Pantaler, E. [7 ]
Yajima, T. [8 ]
Komuro, I. [9 ]
Kadowaki, T. [10 ]
机构：
[1] Oslo Univ Hosp, Oslo, Nydalen, Norway
[2] AstraZeneca, Oslo, Norway
[3] Uppsala Univ, Uppsala, Sweden
[4] Karolinska Inst, Stockholm, Sweden
[5] Statisticon, Uppsala, Sweden
[6] Kantar Hlth GmbH, Munich, Germany
[7] Team Gesundheit GmbH, Essen, Germany
[8] AstraZeneca, Osaka, Japan
[9] Univ Tokyo, Tokyo, Japan
[10] Univ Tokyo Hosp, Tokyo, Japan
来源：
DIABETOLOGIA | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
126
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Cardiorenal Disease Is the Most Common First CV Manifestation in Type 2 Diabetes and Associated with Increased Mortality: A Large Multinational Observational Study
    Birkeland, Kare I.
    Bodegard, Johan
    Thuresson, Marcus
    Eriksson, Jan W.
    Norhammar, Anna
    Yajima, Toshitaka
    Komuro, Issei
    Kadowaki, Takashi
    DIABETES, 2019, 68
  • [2] Cardiorenal disease is the most common first cardiovascular manifestation in type 2 diabetes and associated with increased mortality
    Overbeek, Jetty A.
    Lighaam, Esme
    Linssen, Gerard C. M.
    Herings, Ron M. C.
    Bodegard, Johan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 63 - 64
  • [3] Cardiorenal Disease is the Most Common First CV Manifestation in Type 2 Diabetes
    Olufade, Temitope
    Jiang, Like
    Israni, Rubeen
    Huang, Joanna
    Gosmanov, Aidar
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
  • [4] Cardiorenal disease is the most frequent cardiovascular manifestation in type 2 diabetes and associated with increased cardiovascular death: a large observational study in England
    Zhang, Ruiqi
    Mamza, Jil Billy
    Morris, Tamsin
    Hastings, Rob
    Godfrey, George
    Bodegard, Johan
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
  • [5] Cardiorenal disease is the most common first cardiovascular renal disease manifestation associated with increased mortality risk in early stage of type 2 diabetes patients
    Morita, N.
    Kadowaki, T.
    Komuro, I.
    Yi, P.
    Okami, S.
    Kidani, Y.
    Yajima, T.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S439 - S440
  • [6] Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
    Birkeland, Kare, I
    Bodegard, Johan
    Eriksson, Jan W.
    Norhammar, Anna
    Haller, Hermann
    Linssen, Gerard C. M.
    Banerjee, Amitava
    Thuresson, Marcus
    Okami, Suguru
    Garal-Pantaler, Elena
    Overbeek, Jetty
    Mamza, Jil Billy
    Zhang, Ruiqi
    Yajima, Toshitaka
    Komuro, Issei
    Kadowaki, Takashi
    DIABETES OBESITY & METABOLISM, 2020, 22 (09): : 1607 - 1618
  • [7] Heart Failure and Chronic Kidney Disease Manifestation and Mortality Risk -Associations in Type 2 Diabetes: A Large Multinational Cohort Study
    Birkeland, K. I.
    Bodegard, J.
    Eriksson, J. W.
    Norhammar, A.
    Haller, H.
    Linssen, G. C. M.
    Banerjee, A.
    Thuresson, M.
    Okami, S.
    Garal-Pantaler, E.
    Overbeek, J.
    Mamza, J. B.
    Zhang, R.
    Yajima, T.
    Komuro, I.
    Kadowaki, T.
    DIABETES STOFFWECHSEL UND HERZ, 2021, 30 (01): : 9 - 20
  • [8] Cardiorenal Disease is the Costliest CVD in Type 2 Diabetes: A Large Long-Term Observational Study
    Eriksson, Jan W.
    Bodegard, Johan
    Thuresson, Marcus
    BillyMamza, Jil
    Norhammar, Anna
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 104
  • [9] CARDIORENAL OUTCOMES AND MORTALITY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A MULTINATIONAL PROSPECTIVE COHORT STUDY (PROVALID)
    Thoni, Stefanie
    Keller, Felix
    Denicolo, Sara
    Eder, Susanne
    Rosivall, Laszlo
    Wiecek, Andrzej Jan
    Mark, Patrick
    Rossing, Peter
    Heerspink, Hiddo Lambers
    Mayer, Gert
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [10] Multimorbidity in type 1 diabetes is common and associated with increased mortality
    Ylinen, A.
    Hagg-Holmberg, S.
    Mutter, S.
    Satuli-Autere, S.
    Harjutsalo, V.
    Forsblom, C.
    Groop, P. -H.
    Thorn, L. M.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S81 - S82
12345